NovoCure Financial Ratios
NASDAQ: NVCRHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
NovoCure ratio analysis
NovoCure earned a net margin of -20.8% in FY 2025, up from -27.9% a year earlier. Gross margin was 74.5% compared with a median of 74.8% over the prior 9 years. Return on equity reached -40.0%, meaning NovoCure generated -0.40 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.57 versus 0.27 the year before, and the current ratio was 2.90. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
NovoCure financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | — | — | — | — | — | 961.33 | — | — | — | — |
| Price / sales | 2.23 | 5.38 | 3.12 | 14.27 | 14.51 | 35.33 | 20.75 | 12.45 | 10.10 | 8.10 |
| Price / book | 4.30 | 9.04 | 4.38 | 17.40 | 18.92 | 36.65 | 33.47 | 27.50 | 15.75 | 4.72 |
| Gross margin | 74.5% | 77.3% | 74.8% | 78.6% | 78.5% | 78.5% | 74.8% | 67.7% | 68.6% | 44.2% |
| Operating margin | -23.5% | -28.2% | -45.7% | -16.6% | -8.3% | 6.1% | -0.3% | -13.6% | -22.2% | -139.1% |
| Net margin | -20.8% | -27.9% | -40.6% | -17.2% | -10.9% | 4.0% | -2.1% | -25.6% | -34.8% | -159.1% |
| Free cash flow margin | -11.5% | -11.4% | -19.7% | 1.8% | 11.0% | 17.0% | 4.6% | -3.5% | -22.9% | -136.6% |
| Return on equity (ROE) | -40.0% | -46.8% | -57.1% | -21.0% | -14.2% | 4.2% | -3.3% | -56.6% | -54.3% | -92.6% |
| Return on assets (ROA) | -16.9% | -13.6% | -18.1% | -7.8% | -5.1% | 1.9% | -1.5% | -18.7% | -23.2% | -46.7% |
| Debt / equity | 0.57 | 0.27 | 1.57 | 1.28 | 1.37 | 0.90 | 0.69 | 1.33 | 0.86 | 0.68 |
| Current ratio | 2.90 | 1.46 | 5.78 | 7.00 | 7.53 | 8.80 | 5.10 | 4.98 | 4.88 | 7.10 |
| Revenue growth | 8.3% | 18.8% | -5.3% | 0.5% | 8.2% | 40.7% | 41.6% | 40.1% | 113.6% | 150.5% |
| EPS growth | — | — | — | — | -411.1% | — | — | — | — | — |